Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 225

1.

Evolving Trends in Female to Male Incidence and Male Mortality of Primary Biliary Cholangitis.

Lleo A, Jepsen P, Morenghi E, Carbone M, Moroni L, Battezzati PM, Podda M, Mackay IR, Gershwin ME, Invernizzi P.

Sci Rep. 2016 May 19;6:25906. doi: 10.1038/srep25906.

2.

An Interoperability Platform Enabling Reuse of Electronic Health Records for Signal Verification Studies.

Yuksel M, Gonul S, Laleci Erturkmen GB, Sinaci AA, Invernizzi P, Facchinetti S, Migliavacca A, Bergvall T, Depraetere K, De Roo J.

Biomed Res Int. 2016;2016:6741418. doi: 10.1155/2016/6741418. Epub 2016 Mar 31.

3.

The secretin/secretin receptor axis modulates liver fibrosis through changes in TGF-β1 biliary secretion.

Wu N, Meng F, Invernizzi P, Bernuzzi F, Venter J, Standeford H, Onori P, Marzioni M, Alvaro D, Franchitto A, Gaudio E, Glaser S, Alpini G.

Hepatology. 2016 Apr 26. doi: 10.1002/hep.28622. [Epub ahead of print]

PMID:
27115285
4.

Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).

Banales JM, Cardinale V, Carpino G, Marzioni M, Andersen JB, Invernizzi P, Lind GE, Folseraas T, Forbes SJ, Fouassier L, Geier A, Calvisi DF, Mertens JC, Trauner M, Benedetti A, Maroni L, Vaquero J, Macias RI, Raggi C, Perugorria MJ, Gaudio E, Boberg KM, Marin JJ, Alvaro D.

Nat Rev Gastroenterol Hepatol. 2016 May;13(5):261-80. doi: 10.1038/nrgastro.2016.51. Epub 2016 Apr 20.

PMID:
27095655
5.

Identification of Circulating MicroRNAs in Biliary Atresia by Next-Generation Sequencing.

Peng X, Yang L, Liu H, Pang S, Chen Y, Fu J, Chen Y, Wen Z, Zhang R, Zhu B, Yu J, Invernizzi P.

J Pediatr Gastroenterol Nutr. 2016 Mar 7. [Epub ahead of print]

PMID:
26960174
6.

Serum micrornas as novel biomarkers for primary sclerosing cholangitis and cholangiocarcinoma.

Bernuzzi F, Marabita F, Lleo A, Carbone M, Mirolo M, Marzioni M, Alpini G, Alvaro D, Muri Boberg K, Locati M, Torzilli G, Rimassa L, Piscaglia F, He XS, Bowlus CL, Yang GX, Eric Gershwin M, Invernizzi P.

Clin Exp Immunol. 2016 Feb 10. doi: 10.1111/cei.12776. [Epub ahead of print]

PMID:
26864161
7.

Lack of Siglec-7 expression identifies a dysfunctional natural killer cell subset associated with liver inflammation and fibrosis in chronic HCV infection.

Varchetta S, Mele D, Lombardi A, Oliviero B, Mantovani S, Tinelli C, Spreafico M, Prati D, Ludovisi S, Ferraioli G, Filice C, Aghemo A, Lampertico P, Facchetti F, Bernuzzi F, Invernizzi P, Mondelli MU.

Gut. 2015 Dec 16. pii: gutjnl-2015-310327. doi: 10.1136/gutjnl-2015-310327. [Epub ahead of print]

PMID:
26674359
8.

Geoepidemiology, Genetic and Environmental Risk Factors for PBC.

Zhang H, Carbone M, Lleo A, Invernizzi P.

Dig Dis. 2015;33 Suppl 2:94-101. doi: 10.1159/000440754. Epub 2015 Dec 7.

PMID:
26641264
9.

Making Sense of Autoantibodies in Cholestatic Liver Diseases.

Marzorati S, Invernizzi P, Lleo A.

Clin Liver Dis. 2016 Feb;20(1):33-46. doi: 10.1016/j.cld.2015.08.003. Epub 2015 Oct 9. Review.

PMID:
26593289
10.

A functional magnetic resonance imaging investigation of motor control in Gilles de la Tourette syndrome during imagined and executed movements.

Zapparoli L, Porta M, Gandola M, Invernizzi P, Colajanni V, Servello D, Zerbi A, Banfi G, Paulesu E.

Eur J Neurosci. 2016 Feb;43(4):494-508. doi: 10.1111/ejn.13130. Epub 2015 Dec 23.

PMID:
26566185
11.

Postmarketing Safety Study Tool: A Web Based, Dynamic, and Interoperable System for Postmarketing Drug Surveillance Studies.

Sinaci AA, Laleci Erturkmen GB, Gonul S, Yuksel M, Invernizzi P, Thakrar B, Pacaci A, Cinar HA, Cicekli NK.

Biomed Res Int. 2015;2015:976272. doi: 10.1155/2015/976272. Epub 2015 Oct 12.

12.

Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years.

Selmi C, Ceribelli A, Generali E, Scirè CA, Alborghetti F, Colloredo G, Porrati L, Achenza MI, De Santis M, Cavaciocchi F, Massarotti M, Isailovic N, Paleari V, Invernizzi P, Matthias T, Zucchi A, Meroni PL.

Autoimmun Rev. 2016 Feb;15(2):162-6. doi: 10.1016/j.autrev.2015.10.007. Epub 2015 Oct 30. Review.

PMID:
26524640
13.

INTERPRETATION AND PERCEPTION OF TWO DIFFERENT KUMITE FIGHTING INTENSITIES THROUGH AN INTEGRATED APPROACH TRAINING IN INTERNATIONAL LEVEL KARATEKAS: AN EXPLORATORY STUDY.

Invernizzi PL, Longo S, Bizzi M, Benedini S, Merati G, Bosio A.

Percept Mot Skills. 2015 Oct;121(2):333-49. doi: 10.2466/30.06.PMS.121c19x4. Epub 2015 Oct 7.

PMID:
26445151
14.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Clin Res Hepatol Gastroenterol. 2015 Oct;39(5):e57-9. doi: 10.1016/j.clinre.2015.08.001. No abstract available.

PMID:
26433440
15.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Dig Liver Dis. 2015 Nov;47(11):924-6. doi: 10.1016/j.dld.2015.08.007. Epub 2015 Sep 26. No abstract available.

16.

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Am J Gastroenterol. 2015 Nov;110(11):1536-8. doi: 10.1038/ajg.2015.312. Epub 2015 Sep 29. No abstract available.

17.

Elevated circulating CD14lowCD16+ monocyte subset in primary biliary cirrhosis correlates with liver injury and promotes Th1 polarization.

Peng A, Ke P, Zhao R, Lu X, Zhang C, Huang X, Tian G, Huang J, Wang J, Invernizzi P, Chen Q, Zhuang J.

Clin Exp Med. 2015 Sep 24. [Epub ahead of print]

PMID:
26403460
18.

International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways.

Cordell HJ, Han Y, Mells GF, Li Y, Hirschfield GM, Greene CS, Xie G, Juran BD, Zhu D, Qian DC, Floyd JA, Morley KI, Prati D, Lleo A, Cusi D; Canadian-US PBC Consortium; Italian PBC Genetics Study Group; UK-PBC Consortium, Gershwin ME, Anderson CA, Lazaridis KN, Invernizzi P, Seldin MF, Sandford RN, Amos CI, Siminovitch KA.

Nat Commun. 2015 Sep 22;6:8019. doi: 10.1038/ncomms9019.

19.

Changing Nomenclature for PBC: From 'Cirrhosis' to 'Cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

Clin Gastroenterol Hepatol. 2015 Nov;13(11):1867-9. doi: 10.1016/j.cgh.2015.08.025. Epub 2015 Sep 18. No abstract available.

PMID:
26386643
20.

Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'.

Beuers U, Gershwin ME, Gish RG, Invernizzi P, Jones DE, Lindor K, Ma X, Mackay IR, Parés A, Tanaka A, Vierling JM, Poupon R.

J Hepatol. 2015 Nov;63(5):1285-7. doi: 10.1016/j.jhep.2015.06.031. Epub 2015 Sep 15. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk